Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16540
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAubron, Cécile-
dc.contributor.authorFlint, Andrew W-
dc.contributor.authorBailey, Michael-
dc.contributor.authorPilcher, David-
dc.contributor.authorCheng, Allen C-
dc.contributor.authorHegarty, Colin-
dc.contributor.authorMartinelli, Antony-
dc.contributor.authorReade, Michael C-
dc.contributor.authorBellomo, Rinaldo-
dc.contributor.authorMcQuilten, Zoe-
dc.date2017-01-06-
dc.date.accessioned2017-01-24T23:12:16Z-
dc.date.available2017-01-24T23:12:16Z-
dc.date.issued2017-01-06-
dc.identifier.citationCritical Care 2017; 21: 2en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16540-
dc.description.abstractBACKGROUND: Platelets are commonly transfused to critically ill patients. Reports suggest an association between platelet transfusion and infection. However, there is no large study to have determined whether platelet transfusion in critically ill patients is associated with hospital-acquired infection. METHODS: We conducted a multi-centre study using prospectively maintained databases of two large academic intensive care units (ICUs) in Australia. Characteristics of patients who received platelets in ICUs between 2008 and 2014 were compared to those of patients who did not receive platelets. Association between platelet administration and infection (bacteraemia and/or bacteriuria) was modelled using multiple logistic regression and Cox regression, with blood components as time-varying covariates. A propensity covariate adjustment was also performed to verify results. RESULTS: Of the 18,965 patients included, 2250 (11.9%) received platelets in ICU with a median number of 1 platelet unit (IQR 1-3) administered. Patients who received platelets were more severely ill at ICU admission (mean Acute Physiology and Chronic Health Evaluation III score 65 (SD 29) vs 52 (SD 25), p < 0.01) and had more comorbidities (31% vs 19%, p < 0.01) than patients without platelet transfusion. Invasive mechanical ventilation (87% vs 57%, p < 0.01) and renal replacement therapy (20% vs 4%, p < 0.01) were more frequently administered in patients receiving platelets than in patients without platelets. On univariate analysis, platelet transfusion was associated with hospital-acquired infection in the ICU (7.7% vs 1.4%, p < 0.01). After adjusting for confounders, including other blood components administered, patient severity, centre, year, and diagnosis category, platelet transfusions were independently associated with infection (adjusted OR 2.56 95% CI 1.98-3.31, p < 0.001). This association was also found in survival analysis with blood components as time-varying covariates (adjusted HR 1.85, 95% CI 1.41-2.41, p < 0.001) and when only bacteraemia was considered (adjusted OR 3.30, 95% CI 2.30-4.74, p <0.001). Platelet transfusions remained associated with infection after propensity covariate adjustment. CONCLUSIONS: After adjustment for confounders, including patient severity and other blood components, platelet transfusion was independently associated with ICU-acquired infection. Further research aiming to better understand this association and to prevent this complication is warranted.en_US
dc.subjectBacteraemiaen_US
dc.subjectCritically ill patientsen_US
dc.subjectHospital-acquired infectionen_US
dc.titleIs platelet transfusion associated with hospital-acquired infections in critically ill patients?en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleCritical Careen_US
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationRéanimation Médicale, Centre Hospitalier et Universitaire de Brest site La Cavale Blanche - Université de Bretagne Occidentale, Brest Cedex, Franceen_US
dc.identifier.affiliationJoint Health Command, Australian Defence Force, Canberra, Australian Capital Territory, Australiaen_US
dc.identifier.affiliationIntensive Care Unit, The Alfred Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Infectious Disease, The Alfred Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationTransfusion Service, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationBurns Trauma and Critical Care Research Centre, University of Queensland, Herston, Queensland, Australiaen_US
dc.identifier.affiliationIntensive Care Unit, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationTransfusion Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/28057057en_US
dc.identifier.doi10.1186/s13054-016-1593-xen_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-1650-8939-
dc.type.austinJournal Articleen_US
local.name.researcherBellomo, Rinaldo
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

16
checked on Apr 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.